Savers Value Village Insider Sales: 9,052 Shares Planned; 128,567 Recently Sold

Rhea-AI Filing Summary

Savers Value Village, Inc. (SVV) filing a Form 144 shows a proposed sale of 9,052 common shares through Fidelity Brokerage Services with an aggregate market value of $118,051.60, to be sold on 09/24/2025 on the NYSE. The securities were acquired as an option granted on 06/12/2019 and exercised/acquired on 09/24/2025 with cash payment.

The filing also discloses multiple insider sales by Richard Medway over the prior three months totaling 128,567 shares sold between 07/03/2025 and 09/18/2025, with individual sale sizes ranging from 600 to 45,735 shares. The notice includes the required attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Form 144 filed and compliant with Rule 144 disclosure requirements, listing broker, quantities, and acquisition details
• Seller attestation included stating no known undisclosed material adverse information

Negative

• Large insider selling activity: 128,567 shares sold between 07/03/2025 and 09/18/2025, which is substantial in absolute terms
• No stated 10b5-1 plan adoption date or explanation for sales provided in the filing

Insights

Securities Analyst

TL;DR: Significant insider selling disclosed; routine Form 144 compliance, monitor absolute size and timing for context.

The filing documents a proposed sale of 9,052 shares and extensive prior sales totaling 128,567 shares over roughly two and a half months. From a trading-impact perspective, the volume of insider dispositions is material in absolute terms and may affect float and short-term supply. The securities being sold were acquired via options granted in 2019 and appear to be exercised/settled on 09/24/2025, with cash payment noted. The disclosure meets Rule 144 notice requirements and includes the seller's attestation regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Filing shows transparent disclosure of insider sales; governance implications depend on reasons for sales, not stated here.

The Form 144 properly identifies the broker, class, quantities, and acquisition details including an option grant date of 06/12/2019. Multiple sales by the same individual are reported with dates and gross proceeds, which provides transparency for shareholders. The filing does not provide motivations or a 10b5-1 plan adoption date, so governance assessment is limited to observing that required public notice has been made.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9052	118051.60	155555984	09/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/24/2025	Option Granted - 06/12/2019	Issuer			9052	09/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/03/2025	17619	187642.35
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/18/2025	1800	18950.94
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/22/2025	600	6306.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/23/2025	4228	44415.99
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/31/2025	2637	27641.56
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/01/2025	45735	505108.16
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/04/2025	15000	172200.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/29/2025	15000	179700.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/02/2025	17500	218912.75
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/05/2025	2300	29900.46
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/11/2025	1333	17363.79
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/17/2025	3615	46931.74
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/18/2025	1200	15582.48

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for SVV disclose about upcoming insider sales?

The filing discloses a proposed sale of 9,052 common shares on 09/24/2025 through Fidelity Brokerage Services with aggregate market value $118,051.60.

How many SVV shares did the insider sell in the past three months?

The filing lists prior sales by Richard Medway totaling 128,567 shares sold between 07/03/2025 and 09/18/2025.

How were the shares being sold acquired according to the Form 144?

The securities to be sold were acquired via an option granted on 06/12/2019 and recorded as acquired on 09/24/2025, with payment listed as cash.

Which broker is handling the proposed SVV sale?

The proposed sale is through Fidelity Brokerage Services LLC located at 900 Salem Street, Smithfield, RI, and is to occur on the NYSE.

Does the filing state whether a 10b5-1 trading plan was used?

No. The filing does not provide a date of plan adoption or state that a 10b5-1 plan is in place.